Integrin α3β1 as a breast cancer target

Author： Subbaram Sita DiPersio C Michael

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.10, 2011-10, pp. : 1197-1210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IIb

Current Drug Targets, Vol. 16, Iss. 13, 2015-12 ,pp. : 1429-1437

Bentham Science Publishers

Access to resources Recommend Favorite

CXCL3 is a Potential Target for Breast Cancer Metastasis

Current Cancer Drug Targets, Vol. 14, Iss. 3, 2014-03 ,pp. : 294-309

Bentham Science Publishers

Access to resources Recommend Favorite

The Novel RAR#946; Isoform (#946; 5) is a Potential Target of Retinoids in Breast Cancer

Current Cancer Drug Targets, Vol. 9, Iss. 2, 2009-03 ,pp. : 142-147

Bentham Science Publishers

Access to resources Recommend Favorite

KTS and RTS-Disintegrins: Anti-Angiogenic Viper Venom Peptides Specifically Targeting the 1&bgr; 1 Integrin

Current Pharmaceutical Design, Vol. 13, Iss. 28, 2007-10 ,pp. : 2853-2859

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-α4β1 integrin antibody induces receptor internalization and does not impair the function of circulating neutrophilic leukocytes

By Fleming Jennifer Bao Feng Cepinskas Gediminas Weaver Lynne

Inflammation Research, Vol. 59, Iss. 8, 2010-08 ,pp. : 647-657

Springer Publishing Company

Access to resources Recommend Favorite